OnKure Therapeutics, Inc. Class A Common Stock (OKUR)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 45
- Market Cap
- $159M
About OnKure Therapeutics, Inc. Class A Common Stock
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
SentiSense also tracks daily options readings for OnKure Therapeutics, Inc. Class A Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
OnKure Therapeutics, Inc. Class A Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.